142 related articles for article (PubMed ID: 15526334)
1. Peptide-chelating agent conjugate for selective targeting of somatostatin receptor type 1: synthesis and characterization.
Mansi R; Tesauro D; De Capua A; Fattorusso R; Caracò C; Aloj L; Benedetti E; Morelli G
Biopolymers; 2004; 76(6):527-34. PubMed ID: 15526334
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo evaluation of 111In-DTPAGlu-G-CCK8 for cholecystokinin-B receptor imaging.
Aloj L; Caracò C; Panico M; Zannetti A; Del Vecchio S; Tesauro D; De Luca S; Arra C; Pedone C; Morelli G; Salvatore M
J Nucl Med; 2004 Mar; 45(3):485-94. PubMed ID: 15001692
[TBL] [Abstract][Full Text] [Related]
3. Development of a selective agonist at the somatostatin receptor subtype sstr1.
Liapakis G; Hoeger C; Rivier J; Reisine T
J Pharmacol Exp Ther; 1996 Mar; 276(3):1089-94. PubMed ID: 8786539
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for the binding specificity of a SSTR1-selective analog of somatostatin.
Chen L; Hoeger C; Rivier J; Fitzpatrick VD; Vandlen RL; Tashjian AH
Biochem Biophys Res Commun; 1999 May; 258(3):689-94. PubMed ID: 10329447
[TBL] [Abstract][Full Text] [Related]
5. Bis(hydroxamamide)-based bifunctional chelating agent for 99mTc labeling of polypeptides.
Xu LC; Nakayama M; Harada K; Kuniyasu A; Nakayama H; Tomiguchi S; Kojima A; Takahashi M; Ono M; Arano Y; Saji H; Yao Z; Sakahara H; Konishi J; Imagawa Y
Bioconjug Chem; 1999; 10(1):9-17. PubMed ID: 9893958
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin receptor-binding peptides suitable for tumor radiotherapy with Re-188 or Re-186. Chemistry and initial biological studies.
Cyr JE; Pearson DA; Wilson DM; Nelson CA; Guaraldi M; Azure MT; Lister-James J; Dinkelborg LM; Dean RT
J Med Chem; 2007 Mar; 50(6):1354-64. PubMed ID: 17315859
[TBL] [Abstract][Full Text] [Related]
7. Pyrazolyl derivatives as bifunctional chelators for labeling tumor-seeking peptides with the fac-[M(CO)3]+ moiety (M = 99mTc, Re): synthesis, characterization, and biological behavior.
Alves S; Paulo A; Correia JD; Gano L; Smith CJ; Hoffman TJ; Santos I
Bioconjug Chem; 2005; 16(2):438-49. PubMed ID: 15769099
[TBL] [Abstract][Full Text] [Related]
8. SSTR1- and SSTR3-selective somatostatin analogues.
Ramón R; Martín-Gago P; Verdaguer X; Macias MJ; Martin-Malpartida P; Fernández-Carneado J; Gomez-Caminals M; Ponsati B; López-Ruiz P; Cortés MA; Colás B; Riera A
Chembiochem; 2011 Mar; 12(4):625-32. PubMed ID: 21259412
[TBL] [Abstract][Full Text] [Related]
9. Trifunctional somatostatin-based derivatives designed for targeted radiotherapy using auger electron emitters.
Ginj M; Hinni K; Tschumi S; Schulz S; Maecke HR
J Nucl Med; 2005 Dec; 46(12):2097-103. PubMed ID: 16330576
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of a sulfated and a non-sulfated cyclic CCK8 analogue functionalized with a chelating group for metal labelling.
De Luca S; Morelli G
J Pept Sci; 2004 May; 10(5):265-73. PubMed ID: 15160838
[TBL] [Abstract][Full Text] [Related]
11. Micelles by self-assembling peptide-conjugate amphiphile: synthesis and structural characterization.
Accardo A; Tesauro D; Del Pozzo L; Mangiapia G; Paduano L; Morelli G
J Pept Sci; 2008 Aug; 14(8):903-10. PubMed ID: 18320561
[TBL] [Abstract][Full Text] [Related]
12. The world of beta- and gamma-peptides comprised of homologated proteinogenic amino acids and other components.
Seebach D; Beck AK; Bierbaum DJ
Chem Biodivers; 2004 Aug; 1(8):1111-239. PubMed ID: 17191902
[TBL] [Abstract][Full Text] [Related]
13. Conformational analysis of a potent SSTR3-selective somatostatin analogue by NMR in water solution.
Gairí M; Saiz P; Madurga S; Roig X; Erchegyi J; Koerber SC; Reubi JC; Rivier JE; Giralt E
J Pept Sci; 2006 Feb; 12(2):82-91. PubMed ID: 16365912
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin receptor 1 selective analogues: 3. Dicyclic peptides.
Rivier JE; Kirby DA; Erchegyi J; Waser B; Eltschinger V; Cescato R; Reubi JC
J Med Chem; 2005 Jan; 48(2):515-22. PubMed ID: 15658865
[TBL] [Abstract][Full Text] [Related]
15. Radiolabeled new somatostatin analogs conjugated to DOMA chelator used as targeted tumor imaging agent: synthesis and radiobiological evaluation.
De K; Banerjee I; Misra M
Amino Acids; 2015 Jun; 47(6):1135-53. PubMed ID: 25743164
[TBL] [Abstract][Full Text] [Related]
16. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
Siehler S; Nunn C; Zupanc GK; Hoyer D
Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
[TBL] [Abstract][Full Text] [Related]
17. Modulation of pharmacokinetics of radioiodinated sugar-conjugated somatostatin analogues by variation of peptide net charge and carbohydration chemistry.
Schottelius M; Rau F; Reubi JC; Schwaiger M; Wester HJ
Bioconjug Chem; 2005; 16(2):429-37. PubMed ID: 15769098
[TBL] [Abstract][Full Text] [Related]
18. A bioactive somatostatin analog without a type II' beta-turn: synthesis and conformational analysis in solution.
Jiang S; Gazal S; Gelerman G; Ziv O; Karpov O; Litman P; Bracha M; Afargan M; Gilon C; Goodman M
J Pept Sci; 2001 Oct; 7(10):521-8. PubMed ID: 11695647
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization, and labeling with 99mTc/188Re of peptide conjugates containing a dithia-bisphosphine chelating agent.
Gali H; Hoffman TJ; Sieckman GL; Owen NK; Katti KV; Volkert WA
Bioconjug Chem; 2001; 12(3):354-63. PubMed ID: 11353532
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and metal binding of novel Pseudo- oligopeptides containing two phosphinic acid groups.
Ye Y; Liu M; Kao JL; Marshall GR
Biopolymers; 2008 Jan; 89(1):72-85. PubMed ID: 17910046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
